Gabriela Kania
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gabriela Kania has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Alan Valaperti
From the Division of Cardioimmunology (G.K., P.B., D.G., U.E.), Institute of Physiology, University of Zurich; Experimental Critical Care (G.K., P.B., A.V., D.G., U.E.), Department of Biomedicine, University Hospital, Basel; Cardiovascular Research and Zurich Center for Integrative Human Physiology (S.S., C.M.M.), University of Zurich; Institute of Pathology (S.D.), University Hospital, Basel; Department of Internal Medicine (L.H.), University Hospital, Basel; and Cardiology (C.M.M., U.E.),...
1 shared publicationChristian M. Matter
From the Division of Cardioimmunology (G.K., P.B., D.G., U.E.), Institute of Physiology, University of Zurich; Experimental Critical Care (G.K., P.B., A.V., D.G., U.E.), Department of Biomedicine, University Hospital, Basel; Cardiovascular Research and Zurich Center for Integrative Human Physiology (S.S., C.M.M.), University of Zurich; Institute of Pathology (S.D.), University Hospital, Basel; Department of Internal Medicine (L.H.), University Hospital, Basel; and Cardiology (C.M.M., U.E.),...
1 shared publicationDavide Germano
From the Division of Cardioimmunology (G.K., P.B., D.G., U.E.), Institute of Physiology, University of Zurich; Experimental Critical Care (G.K., P.B., A.V., D.G., U.E.), Department of Biomedicine, University Hospital, Basel; Cardiovascular Research and Zurich Center for Integrative Human Physiology (S.S., C.M.M.), University of Zurich; Institute of Pathology (S.D.), University Hospital, Basel; Department of Internal Medicine (L.H.), University Hospital, Basel; and Cardiology (C.M.M., U.E.),...
1 shared publication- Lukas Hunziker
Department of Cardiology, Inselpital, Bern University Hospital, Freiburgstrasse 10 , 3010 Bern
1 shared publication - Przemyslaw Blyszczuk
Department of Clinical Immunology, Faculty of Medicine (M. Stefanska, P.B.), Jagiellonian University Medical College, Cracow, Poland
1 shared publication - Sokrates Stein
Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland
1 shared publication
Latest Publications
- 28 August 2009
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 105 (5) , 462-470
Heart-Infiltrating Prominin-1 + /CD133 + Progenitor Cells Represent the Cellular Source of Transforming Growth Factor β–Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis
Rationale : Myocardial fibrosis is a hallmark of inflammation-triggered end-stage heart disease, a common cause of heart failure in young patients. Objective : We used CD4 + T-cell–mediated experimental autoimmune myocarditis model to determine the parameters regulating cardiac fibrosis in inflammatory heart disease. Methods and Results : α-Myosin heavy chain peptide/complete Freund’s adjuvant immunization was used to induce experimental autoimmune myocarditis in BALB/c mice. Chimeric mice, reconstituted with enhanced green fluorescence protein (EGFP) + bone marrow, were used to track the fate of inflammatory cells. Prominin-1 + cells were isolated from the inflamed hearts, cultured in vitro and injected intracardially at different stages of experimental autoimmune myocarditis. Transforming growth factor (TGF)-β–mediated fibrosis was addressed using anti–TGF-β antibody treatment. Myocarditis peaked 21 days after immunization and numbers of cardiac fibroblasts progressively increased on follow-up. In chimeric mice, >60% of cardiac fibroblasts were EGFP + 46 days after immunization. At day 21, cardiac infiltrates contained ≈30% of prominin-1 + progenitors. In vitro and in vivo experiments confirmed that prominin-1 + but not prominin-1 − cells isolated from acutely inflamed hearts represented the cellular source of cardiac fibroblasts at late stages of disease, characterized by increased TGF-β levels within the myocardium. Mechanistically, the in vitro differentiation of heart-infiltrating prominin-1 + cells into fibroblasts depended on TGF-β–mediated phosphorylation of Smad proteins. Accordingly, anti–TGF-β antibody treatment prevented myocardial fibrosis in immunized mice. Conclusions : Taken together, heart-infiltrating prominin-1 + progenitors are the major source of subsequent TGF-β–triggered cardiac fibrosis in experimental autoimmune myocarditis. Recognizing the critical, cytokine-dependent role of bone marrow–derived progenitors in cardiac remodeling might result in novel treatment concepts against inflammatory heart failure.
- 28 August 2009
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 105 (5) , 462-470
Heart-Infiltrating Prominin-1 + /CD133 + Progenitor Cells Represent the Cellular Source of Transforming Growth Factor β–Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis
Rationale : Myocardial fibrosis is a hallmark of inflammation-triggered end-stage heart disease, a common cause of heart failure in young patients. Objective : We used CD4 + T-cell–mediated experimental autoimmune myocarditis model to determine the parameters regulating cardiac fibrosis in inflammatory heart disease. Methods and Results : α-Myosin heavy chain peptide/complete Freund’s adjuvant immunization was used to induce experimental autoimmune myocarditis in BALB/c mice. Chimeric mice, reconstituted with enhanced green fluorescence protein (EGFP) + bone marrow, were used to track the fate of inflammatory cells. Prominin-1 + cells were isolated from the inflamed hearts, cultured in vitro and injected intracardially at different stages of experimental autoimmune myocarditis. Transforming growth factor (TGF)-β–mediated fibrosis was addressed using anti–TGF-β antibody treatment. Myocarditis peaked 21 days after immunization and numbers of cardiac fibroblasts progressively increased on follow-up. In chimeric mice, >60% of cardiac fibroblasts were EGFP + 46 days after immunization. At day 21, cardiac infiltrates contained ≈30% of prominin-1 + progenitors. In vitro and in vivo experiments confirmed that prominin-1 + but not prominin-1 − cells isolated from acutely inflamed hearts represented the cellular source of cardiac fibroblasts at late stages of disease, characterized by increased TGF-β levels within the myocardium. Mechanistically, the in vitro differentiation of heart-infiltrating prominin-1 + cells into fibroblasts depended on TGF-β–mediated phosphorylation of Smad proteins. Accordingly, anti–TGF-β antibody treatment prevented myocardial fibrosis in immunized mice. Conclusions : Taken together, heart-infiltrating prominin-1 + progenitors are the major source of subsequent TGF-β–triggered cardiac fibrosis in experimental autoimmune myocarditis. Recognizing the critical, cytokine-dependent role of bone marrow–derived progenitors in cardiac remodeling might result in novel treatment concepts against inflammatory heart failure.